Utama › Kanser Ginjal (Karsinoma Sel Renal) › Ohio › Columbus
Kajian klinikal Kanser Ginjal (Karsinoma Sel Renal) di Columbus, OH
13 kajian untuk Kanser Ginjal (Karsinoma Sel Renal) sedang mencari peserta di lokasi dalam dan sekitar Columbus (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- dan 8 lagi
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- dan 11 lagi
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
Mengambil pesertaFasa 2
- Ohio State University Comprehensive Cancer Center, Columbus
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Mengambil pesertaKajian pemerhatian
- The Ohio State University Comprehensive Cancer Center, Columbus
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
Mengambil pesertaFasa 2
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Mengambil pesertaFasa 2
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Mengambil pesertaFasa 3
- Ohio State University Comprehensive Cancer Center, Columbus
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Mengambil pesertaFasa 1
- Xencor Investigative Site, Columbus
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Mengambil pesertaFasa 1/2
- James Cancer Hospital and Solove Research Institute, Columbus
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Ohio State University, Columbus
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- The Ohio State University Wexner Medical Center, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- The Ohio State University, Columbus
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Mengambil pesertaFasa 3
- Ohio State University Comprehensive Cancer Center, Columbus
Kajian Kanser Ginjal (Karsinoma Sel Renal) di bandar lain
- Houston, TX35 kajian
- New York City, NY27 kajian
- Nashville, TN23 kajian
- Dallas, TX23 kajian
- St. Louis, MO23 kajian
- Los Angeles, CA20 kajian
- Boston, MA16 kajian
- Baldwin Park, CA16 kajian
- Philadelphia, PA15 kajian
- Pittsburgh, PA15 kajian
- Queens, NY15 kajian
- Rochester, MN14 kajian
Kajian lain di Columbus
- Kanser Paru-paru Bukan Sel Kecil57 kajian
- Kanser Payudara40 kajian
- Kanser Ovari39 kajian
- Kanser (semua jenis)38 kajian
- Kanser Paru-paru37 kajian
- Leukemia Mieloid Akut35 kajian
- Leukemia Limfositik Kronik28 kajian
- Kanser Metastatik27 kajian
- Kanser Endometrium25 kajian
- Kanser Prostat24 kajian
- Mieloma Pelbagai24 kajian
- Kanser Kolorektal24 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.